Artiva Biotherapeutics, Inc. (ARTV)

Profile

Full Name

Artiva Biotherapeutics, Inc.

Ticker

NASDAQ: ARTV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 19, 2024

Indexes

Not included

Website

https://www.artivabio.com

Employees

96

Key Details

Price

$6.01(116.97%)

Market Cap

$146.42M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$251.00K(-99.25% YoY)

Annual EPS

-$2.69(-64.76% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.01
    ARTV price is $6.01

    30-Day Relative Volume

    24.55
    ARTV 30-day relative volume is 24.55

    Price Performance

    Price Most Recent Change

    +116.97%
    ARTV price was up +116.97% on Oct 17, 2025

    Price YTD Change

    -40.38%
    ARTV price is down -40.38% since January 1st

    Price 1-Year Change

    -52.97%
    ARTV price is down -52.97% year-on-year

    Price 3-Year Change

    -
    ARTV price 3-year change is unknown

    Price Range

    Price All-Time High

    $17.31
    ARTV price is currently -65.28% below its historical high of $17.31

    Price 3-Year Low

    $1.47
    ARTV price is currently +308.84% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $146.42M
    ARTV market cap is $146.42 million

    Market Cap 3-Year Change

    -
    ARTV market cap 3-year change is unknown

    Market Cap All-Time High

    $384.46M
    ARTV market cap is currently -61.92% below its historical high of $384.46 million

    Market Cap Sector Percentile

    45.11%
    ARTV market cap is higher than 45.11% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.31%
    ARTV shares outstanding is up +0.31% year-on-year

    Shares Outstanding 3-Year Change

    +38.56%
    ARTV shares outstanding is up +38.56% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.61
    ARTV beta is 1.61

    200-day SMA

    $3.38
    ARTV price is currently +77.73% above its 200-day simple moving average

    50-day SMA

    $2.90
    ARTV price is currently +106.93% above its 50-day simple moving average

    14-Day RSI

    82.91
    ARTV 14-day relative strength index is 82.91

    Volume

    24.55
    ARTV 30-day relative volume is 24.55

    ATR

    $0.53
    ARTV average true range is $0.53

    10-day Historical Volatility

    594.14%
    ARTV 10-day historical volatility is 594.14%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $251.00K
    ARTV annual revenue is $251.00 thousand

    Revenue Analysts Estimate

    -
    ARTV annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    -99.25%
    ARTV annual revenue is down -99.25% year-on-year

    Revenue Sector Percentile

    33.28%
    ARTV annual revenue is higher than 33.28% of companies in Healthcare sector

    EPS

    EPS

    -$2.69
    ARTV annual earnings per share is -$2.69

    EPS Analysts Estimate

    -$3.13
    ARTV annual earnings per share is currently +14.02% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -64.76%
    ARTV annual earnings per share is down -64.76% year-on-year

    EPS Sector Percentile

    32.49%
    ARTV annual earnings per share is higher than 32.49% of companies in Healthcare sector

    Profit

    Gross Profit

    -$2.18M
    ARTV annual gross profit is -$2.18 million

    Gross Margin

    -868.53%
    ARTV annual gross profit margin is -868.53%

    Operating Profit

    -$68.08M
    ARTV annual operating income is -$68.08 million

    Operating Margin

    -27.12K%
    ARTV annual operating profit margin is -27.12 thousand%

    Net Income

    -$65.37M
    ARTV annual net profit is -$65.37 million

    Net Margin

    -26.05K%
    ARTV annual net profit margin is -26.05 thousand%

    Expenses

    Total Expenses

    $65.62M
    ARTV annual total expenses is $65.62 million

    Operating Expenses

    $65.90M
    ARTV annual total operating expenses is $65.90 million

    Cost Of Goods Sold

    $2.43M
    ARTV annual cost of goods sold is $2.43 million

    Selling, General & Administrative Expenses

    $0.00
    ARTV annual SG&A is $0.00

    Depreciation & Amortization

    $2.43M
    ARTV annual D&A is $2.43 million

    Interest Expense

    $0.00
    ARTV annual interest expense is $0.00

    Income Tax

    $0.00
    ARTV annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$68.08M
    ARTV annual earnings before interest & taxes is -$68.08 million

    EBITDA

    -$65.65M
    ARTV annual EBITDA is -$65.65 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $209.58M
    ARTV annual total assets is $209.58 million

    Non Current Assets

    $20.95M
    ARTV annual long term assets is $20.95 million

    Current Assets

    $188.63M
    ARTV annual total current assets is $188.63 million

    Cash and Cash Equivalents

    $40.23M
    ARTV annual cash & cash equivalents is $40.23 million

    Accounts Receivable

    $0.00
    ARTV annual accounts receivable is $0.00

    Inventory

    $0.00
    ARTV annual inventory is $0.00

    Liabilities

    Total Liabilities

    $22.94M
    ARTV annual total liabilities is $22.94 million

    Long Term Liabilities

    $10.69M
    ARTV annual total long term liabilities is $10.69 million

    Current Liabilities

    $12.25M
    ARTV annual current liabilities is $12.25 million

    Accounts Payable

    $1.12M
    ARTV annual accounts payable is $1.12 million

    Debt

    Total Debt

    $14.35M
    ARTV annual total debt is $14.35 million

    Total Debt 1-Year Change

    -15.13%
    ARTV annual total debt is down -15.13% year-on-year

    Long Term Debt

    $10.61M
    ARTV annual long term debt is $10.61 million

    Short Term Debt

    $3.74M
    ARTV annual short term debt is $3.74 million

    Equity & Capital

    Shareholders Equity

    $186.64M
    ARTV annual stockholders equity is $186.64 million

    Book Value

    $186.64M
    ARTV annual book value is $186.64 million

    Retained Earnings

    -$246.68M
    ARTV annual retained earnings is -$246.68 million

    Working Capital

    $176.38M
    ARTV annual working capital is $176.38 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$55.03M
    ARTV annual cash from operations is -$55.03 million

    Cash From Operations 1-Year Change

    -16.03%
    ARTV annual cash from operations is down -16.03% year-on-year

    Cash From Investing

    -$120.46M
    ARTV annual cash from investing is -$120.46 million

    Cash From Investing 1-Year Change

    -363.77%
    ARTV annual cash from investing is down -363.77% year-on-year

    Cash From Financing

    $162.23M
    ARTV annual cash from financing is $162.23 million

    Cash From Financing 1-Year Change

    +565.11%
    ARTV annual cash from financing is up +565.11% year-on-year

    CAPEX

    CAPEX

    $642.00K
    ARTV annual capital expenditures is $642.00 thousand

    CAPEX 1-Year Change

    -80.29%
    ARTV annual capital expenditures is down -80.29% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$55.67M
    ARTV annual free cash flow is -$55.67 million

    Free Cash Flow 1-Year Change

    -9.84%
    ARTV annual free cash flow is down -9.84% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -868.53%
    ARTV annual gross profit margin is -868.53%

    Operating Margin

    -27.12K%
    ARTV annual operating profit margin is -27.12 thousand%

    Net Margin

    -26.05K%
    ARTV annual net profit margin is -26.05 thousand%

    ROA & ROE

    ROA

    -41.55%
    ARTV annual return on assets is -41.55%

    ROE

    -54.24%
    ARTV annual return on equity is -54.24%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ARTV price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ARTV price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.98
    ARTV price to book ratio is 0.98

    PB Ratio Sector Percentile

    33.02%
    ARTV price to book ratio is higher than 33.02% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    ARTV price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    ARTV price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $17.28M
    ARTV enterprise value is $17.28 million

    Enterprise Value Sector Percentile

    24.64%
    ARTV enterprise value is higher than 24.64% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.22
    ARTV EV/EBITDA is -0.22

    EV/EBITDA Sector Percentile

    61.61%
    ARTV EV/EBITDA is higher than 61.61% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    15.39
    ARTV annual current ratio is 15.39

    Quick Ratio

    15.39
    ARTV annual quick ratio is 15.39

    Leverage

    Debt To Equity

    0.08
    ARTV annual debt to equity ratio is 0.08

    Interest Coverage Ratio

    -
    ARTV annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    ARTV piotroski f-score value is unknown

    Altman Z-Score

    2.12
    ARTV altman z-score is 2.12

    Analyst ratings

    Recent major analysts updates

    Oct 17, 25 Wedbush
    Outperform
    Oct 17, 25 Needham
    Buy
    May 15, 25 Needham
    Buy
    Apr 8, 25 Needham
    Buy
    Mar 26, 25 HC Wainwright & Co.
    Buy
    Mar 25, 25 Wedbush
    Outperform
    Mar 25, 25 Needham
    Buy
    Mar 25, 25 Cantor Fitzgerald
    Overweight
    Dec 30, 24 HC Wainwright & Co.
    Buy
    Nov 13, 24 Needham
    Buy

    Institutional Ownership

    Screeners with ARTV included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Artiva Biotherapeutics, Inc.?
    • Does Artiva Biotherapeutics, Inc. pay dividends?
    • What sector is Artiva Biotherapeutics, Inc. in?
    • What industry is Artiva Biotherapeutics, Inc. in?
    • What country is Artiva Biotherapeutics, Inc. based in?
    • When did Artiva Biotherapeutics, Inc. go public?
    • Is Artiva Biotherapeutics, Inc. in the S&P 500?
    • Is Artiva Biotherapeutics, Inc. in the NASDAQ 100?
    • Is Artiva Biotherapeutics, Inc. in the Dow Jones?
    • When was Artiva Biotherapeutics, Inc.'s last earnings report?
    • When does Artiva Biotherapeutics, Inc. report earnings?

    What is the ticker symbol for Artiva Biotherapeutics, Inc.?

    The ticker symbol for Artiva Biotherapeutics, Inc. is NASDAQ:ARTV

    Does Artiva Biotherapeutics, Inc. pay dividends?

    No, Artiva Biotherapeutics, Inc. does not pay dividends

    What sector is Artiva Biotherapeutics, Inc. in?

    Artiva Biotherapeutics, Inc. is in the Healthcare sector

    What industry is Artiva Biotherapeutics, Inc. in?

    Artiva Biotherapeutics, Inc. is in the Biotechnology industry

    What country is Artiva Biotherapeutics, Inc. based in?

    Artiva Biotherapeutics, Inc. is headquartered in United States

    When did Artiva Biotherapeutics, Inc. go public?

    Artiva Biotherapeutics, Inc.'s initial public offering (IPO) was on July 19, 2024

    Is Artiva Biotherapeutics, Inc. in the S&P 500?

    No, Artiva Biotherapeutics, Inc. is not included in the S&P 500 index

    Is Artiva Biotherapeutics, Inc. in the NASDAQ 100?

    No, Artiva Biotherapeutics, Inc. is not included in the NASDAQ 100 index

    Is Artiva Biotherapeutics, Inc. in the Dow Jones?

    No, Artiva Biotherapeutics, Inc. is not included in the Dow Jones index

    When was Artiva Biotherapeutics, Inc.'s last earnings report?

    Artiva Biotherapeutics, Inc.'s most recent earnings report was on August 7, 2025

    When does Artiva Biotherapeutics, Inc. report earnings?

    The date for Artiva Biotherapeutics, Inc.'s next earnings report has not been announced yet
    On this page